194
Participants
Start Date
July 29, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2026
Mount Sinai West, New York
Weill Cornell Medicine - New York Presbyterian Hospital, New York
University of Rochester Medical Center, Rochester
Universitätsmedizin Rostock, Rostock
University of Miami Health System, Miami
Movement Disorders Center of Boca Raton, Boca Raton
Klinik und Poliklinik für Neurologie am Standort Marburg, Marburg
Azienda Ospedale Università Padova, Padua
Complexo Hospitalario de Pontevedra (CHOP), Pontevedra
Vanderbilt University Medical Center, Nashville
University of Louisville, Louisville
Universitaetsklinikum Duesseldorf AöR, Düsseldorf
Hospital Universitario Virgen del Rocio, Seville
Cleveland Clinic, Cleveland
Hospital Universitario Y Politécnico La Fe, Valencia
Hospital San Juan de Dios, Santurtzi
AOU Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi, Ancona
Parkinson's Disease and Movement Disorders Center at Northwestern University Feinberg School of Medicine, Chicago
University of Kansas Medical Center, Kansas City
University Hospital Tuebingen, Tübingen
Dkd Wiesbaden, Wolfach
University of Colorado, Aurora
Klinikum der Universität München - Campus Grosshadern, Munich
Technischen Universitaet Muenchen (TUM), Munich
AOU OO.RR. San Giovanni di Dio Ruggi d'Aragona, Salerno
Mayo Clinic Neurology, Scottsdale
David Geffen School of Medicine University of California Los Angeles, Los Angeles
University of California, Irvine, Orange
Universitätsklinikum Würzburg - Medizinische Klinik, Würzburg
Evergreen Health Medical Center, Kirkland
Tufts Medical Center, Boston
Toronto Western Hospital, Toronto
IRCCS San Raffaele Pisana, Rome
Hospital de la Santa Creu i Sant Pau, Barcelona
Lead Sponsor
BlueRock Therapeutics
INDUSTRY